Insider Cluster (2 insiders) ·Filed Sep 3, 2026

ALKS

Alkermes plc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed28d 18h ago
Insider cluster: 2 insiders, $521K total
Actionable Insight • Neutral

No actionable signal. The cluster is too small to move the stock and the CMO's sales are consistent with option exercise/tax planning. Monitor next 8-K or earnings for any fundamental catalyst, but this filing alone does not warrant a trade.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d
ALKS ▼ -0.59% at T+5d
NEUTRAL call ✗ call lost -0.59% · α vs SPY +0.62% · entry $46.10 → $45.83
Next anchor: T+20d due 6h ago
Latest observation: T+18 -9.87% FF3 residual α
Entry anchored
Sep 3, 05:24 PM ET
via 1-min bar
T+1d
-1.32%
call -1.32% · α -0.77%
$45.49
settled 28d ago
T+5d
-0.59%
call -0.59% · α +0.62%
$45.83
settled 21d ago
T+20d
—
call — · α —
—
due 6h ago
T+60d
—
call — · α —
—
in 8w

Price Chart

Loading chart...

Executive Summary

Two senior Alkermes executives (EVP/CLO and EVP R&D/CMO) sold a combined $521K in open-market shares over a 3-day window. The CMO's sales followed derivative exercises, suggesting a tax/vesting-driven pattern rather than a purely bearish signal. At 0.0065% of Alkermes' $8.0B market cap, the dollar value is trivial and well below the 0.1% materiality threshold for insider clusters. This is a routine, non-informational cluster — no actionable signal for traders.

Key Financial Metrics

Direction
selling
Total Value
$521.0K
Insiders
2

Key Facts

  • Two senior executives sold shares totaling $521K in a 3-day window
  • CMO Hopkinson sold 9K shares at $46.99 after exercising 10K options at $24.59 and $0 — typical tax/vesting pattern
  • CLO Gaffin sold 2K shares at $48.01 — a small, likely routine sale
  • Total sales represent 0.0065% of Alkermes' $8.0B market cap — far below the 0.1% materiality threshold
  • No insider buying in the cluster to offset the sales

Financial Impact

Total insider sales of $521K represent 0.0065% of market cap — economically trivial

insider_ownership

Risk Factors

  • Insider sales could accelerate if the stock continues to rise, but current volume is immaterial
  • No buying activity to offset the sales — a lack of bullish insider conviction

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
76% bullish (25 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ALKS-1788476477349
18 reports for ALKS
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +25.88%May 12, 2026
Filters
Rows
Reports for ALKS — sortable, filterable
TypeNow
Sep 16, 2026
16d ago
8-K
NEUTRAL ★ 2/10
$46.07 $42.13▼ −8.55%▼ −11.12%$41.60 (−9.70%)
Sep 3, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$46.10 $45.83▼ −0.59%▲ +0.62%$41.60 (−9.76%)
Aug 3, 2026
8w ago
Insider Cluster
BEARISH ★ 4/10
$49.67 $49.21▲ +0.93%▲ +0.83%$41.60 (+16.25%)
Aug 3, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$49.67 $49.21▼ −0.93%▼ −0.83%$41.60 (−16.25%)
Aug 3, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$49.67 $49.21▼ −0.93%▼ −0.83%$41.60 (−16.25%)
Jul 28, 2026
9w ago
8-K
BEARISH ★ 6/10
$50.50 $49.53▲ +1.92%▲ +4.19%$41.60 (+17.62%)
Jul 8, 2026
12w ago
8-K
NEUTRAL ★ 3/10
$54.29 $51.60▼ −4.95%▼ −5.82%$41.60 (−23.37%)
Jul 6, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$55.14 $51.94▼ −5.80%▼ −6.29%$41.60 (−24.56%)
Jun 4, 2026
17w ago
Insider Cluster
NEUTRAL ★ 3/10
$42.80 $44.28▲ +3.46%▲ +2.89%$41.60 (−2.80%)
Jun 1, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$41.19 $44.29▲ +7.53%▲ +10.50%$41.60 (+1.00%)
Showing 10 of 18

US Market Status

Market Open — Closes in 2h 11m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Sep 3, 2026